Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Feraheme MRI for Pancreatic Cancer Staging
NCT00920023Phase 4Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Jul 2008
- Primary completion
- Feb 2012
- Countries
- 1
01
Overview
A Phase 4 trial of ferumoxytol in pancreatic cancer (PC), sponsored by Massachusetts General Hospital. Started Jul 2008; status: completed.
02
Drugs
ferumoxytol
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00920023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00920023.